The target of daptomycin is absent from Escherichia coli and other gram-negative pathogens

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 637-639

  Randall, Christopher P ^a   Mariner, Katherine R ^a   Chopra, Ian ^a   O'Neill, Alex J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINONIN; CLINDAMYCIN; CLOFAZIMINE; DAPTOMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; INDOLMYCIN; LINEZOLID; NISIN; NOVOBIOCIN; POLYMYXIN B NONAPEPTIDE; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; CELL MEMBRANE; DRUG EFFICACY; DRUG TARGETING; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MICROCYSTIS AERUGINOSA; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; PROTOPLAST; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DAPTOMYCIN; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 84872040228     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02005-12     Document Type: Article

References (17)

1. Chopra I, Schofield C, Everett M, O'Neill A, Miller K, Wilcox M, Frere JM, Dawson M, Czaplewski L, Urleb U, Courvalin P. 2008. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect. Dis. 8:133-139.
2. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
3. Kalan L, Wright GD. 2011. Antibiotic adjuvants: multicomponent antiinfective strategies. Expert Rev. Mol. Med. 13:e5. doi:10.1017/ S1462399410001766.
4. Gordon NC, Png K, Wareham DW. 2010. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:5316-5322.
5. Taylor PL, Rossi L, De Pascale G, Wright GD. 2012. A forward chemical screen identifies antibiotic adjuvants in Escherichia coli. ACS Chem. Biol. 7:1547-1555.
6. Bohnert JA, Kern WV. 2005. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49:849-852.
7. Mamelli L, Amoros JP, Pages JM, Bolla JM. 2003. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int. J. Antimicrob. Agents 22:237-241.
8. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed, vol 32, no. 2. Approved standard M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
9. O'Neill AJ, Bostock JM, Moita AM, Chopra I. 2002. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J. Antimicrob. Chemother. 50:839-848.
10. O'Neill AJ. 2010. Staphylococcus aureus SH1000 and 8325-4: comparative genome sequences of key laboratory strains in staphylococcal research. Lett. Appl. Microbiol. 51:358-361.
11. Dai M, Ziesman S, Ratcliffe T, Gill RT, Copley SD. 2005. Visualization of protoplast fusion and quantitation of recombination in fused protoplasts of auxotrophic strains of Escherichia coli. 2005. Metab. Eng. 7:45-52.
12. Hobbs JK, Miller K, O'Neill AJ, Chopra I. 2008. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. J. Antimicrob. Chemother. 62:1003-1008.
13. Jung D, Rozek A, Okon M, Hancock RE. 2004. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol. 11:949-957.
14. Epand RF, Savage PB, Epand RM. 2007. Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (ceragenins). Biochim. Biophys. Acta 1768:2500-2509.
15. StGelais C, Tuthill TJ, Clarke DS, Rowlands DJ, Harris M, Griffin S. 2007. Inhibition of hepatitisCvirus p7 membrane channels in a liposome-based assay system. Antiviral Res. 76:48-58.
16. Oliva B, O'Neill AJ, Miller K, Stubbings W, Chopra I. 2004. Antistaphylococcal activity and mode of action of clofazimine. J. Antimicrob. Chemother. 53:435-440.
17. Epand RF, Pollard JE, Wright JO, Savage PB, Epand RM. 2010. Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins. Antimicrob. Agents Chemother. 54:3708-3713.